undamentalytics Newsletter
Sign in

Ardelyx, Inc. cash flow statement

In fiscal 2025, Ardelyx, Inc.'s operations generated −$42.5m of cash; it spent $1.5m on capital projects, leaving free cash flow of −$44.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations22213−72−65−70−76−81−153−70−90−45−42−17
Depreciation and amortisation11013333311233
Stock-based pay00231091011121114374955
Capital spending00232000200111
Free cash flow22212−75−68−71−77−82−154−70−90−46−44−18
Free cash flow after stock pay21110−78−77−80−87−92−166−81−104−83−93−73
Share buybacks000———————————
Shares issued——6174——0211017211900—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ARDX vs CRMDARDX vs ARQTARDX vs KRYS

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Ardelyx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ardelyx, Inc.